Chris Wilson is an associate in the Washington, D.C. office of Gibson Dunn & Crutcher LLP.  He is a member of the firm’s Antitrust and Competition Practice Group.

Mr. Wilson assists clients in navigating DOJ and FTC investigations and private party litigation involving complex antitrust and consumer protection issues, including matters implicating the Sherman Act, the Clayton Act, the FTC Act, and the Hart-Scott-Rodino (HSR) merger review process.  His experience crosses multiple industries, including health insurance, transportation, telecommunications, energy, agriculture, and biotechnology, and his particular areas of focus include vertical merger enforcement, interlocking directorates, joint ventures, and employee “no-poach” agreements.  He is also well-versed in cross-border investigations, having worked cooperatively with antitrust enforcement authorities in the European Union, Canada, and Brazil during his time at the Department of Justice.

Prior to joining the firm, Mr. Wilson was a trial attorney in the Antitrust Division of the U.S. Department of Justice.  During his tenure, Mr. Wilson played a prominent role in numerous high profile matters, and he received the Antitrust Division’s Award of Distinction on two separate occasions. Before joining the Department of Justice, Mr. Wilson was an associate in Gibson Dunn’s Dallas office.  He is a graduate of Columbia Law School, where he was a Harlan Fiske Stone scholar, and holds a B.A. in Economics from New York University.  He is also a member of the Health Care and Pharmaceuticals Committee of the ABA Section of Antitrust Law.

Mr. Wilson is admitted to practice in California, Texas, and the District of Columbia.